Clinical Trial Update: Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of docetaxel, gemcitabine, and bevacizumab in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: University Hospital of Crete | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED